Sandrine Marchais-Oberwinkler

3PUBLICATIONS
5CO-AUTHORS
Clinical pharmacology and therapeuticsMolecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.

Ahmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger

|Jan 16, 2019
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.

Ahmed S Abdelsamie, Steven Herath, Yannik Biskupek

|Nov 28, 2018
Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis Therapy.

Lorenz Siebenbuerger, Victor Hernandez-Olmos, Ahmed S Abdelsamie

Pageof 1

Frequent Collaborators

3 joint publications

Martin Frotscher

3 joint publications

Chris J van Koppen

3 joint publications

Rolf W Hartmann

2 joint publications

Ahmed S Abdelsamie